The antibody response to immunization with Brucella and the levels of natural antibody to Escherichia coli and Shigella were compared in patients with systemic lupus erythematosus and control groups. After Brucella immunization, SLE patients showed a significantly lower antibody response in whole serum and in the macroglobulin antibody fraction separated by sucrose density gradient centrifugation.
INTRODUCTION
Previous studies have reported an increased antibody response in patients with systemic lupus erythematosis (SLE) after immunization with Brucella (1) and incompatible erythrocytes (2) , and a normal or decreased Dr. Baum is a Clinical Scholar of the Arthritis Foundation. His present address is Department of Medicine, University of Rochester School of Medicine, Rochester, N. Y.
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Received for publication 13 August 1968 and in revised form 21 December 1968. response after immunization with tetanus (3). Spontaneous isoagglutinin levels and antibody to Proteus OX-2 were found by Muschel (4) to be normal whereas ASO levels were lower than in controls. The class of immunoglobulin response has not been measured in any of these studies, though it has been shown to be predominantly of the 7S variety in the case of the antinuclear antibody (5, 6) . In the present study, the response of SLE patients and a group of normal individuals to stimulation with Brucella antigen has been determined, and the titers of 19S (IgM) and 7S (IgG) Brucella antibody measured. Since natural antibodies to E. coli (7) and Shigella (8) are frequently found, the whole serum, 19S and 7S antibody titers of these antibodies were compared with the patient and control groups. METHODS Brucella immunization. 23 female patients with SLE were immunized (Table I) . 18 were black, 4 white, and one, Latin-American. Every patient had had a positive antinuclear test and all had positive LE cell tests at some time in their disease course. The mean age was 34 yr (range, 14-66 yr) . 16 patients were receiving Prednisone, the average dosage being 13 mg daily (2.5-25 mg). Three patients were receiving 6-mercaptopurine, two 25 mg and one, 75 mg daily. Six patients were immunized within the 1st 6 months of their illness, whereas one patient had known disease for 12 yr. The average duration of disease was 32 months. The control group was composed of 18 student nurses with an average age of 21 yr (range, 20-23 yr). 17 were white and one was black.
Immunization was performed with undulant fever vaccine (Parke, Davis & Co.), injecting 0.1 ml in a single subcutaneous immunizing dose containing 2 X 108 organisms (10' Brucella abortus and 10' Brucella melitensis). Controls and patients were bled before immunization, and at 1, 4, and 12 wk postimmunization. Three patients were not bled until 16 wk postimmunization. 15 of the patients with SLE were reboosted with the same dosage of Brucella antigen. They were bled as before at 1, 4, and 12 wk, and the Brucella antibody titers were again measured. Antibody titers were determined by a modification of the standard agglutination method (9). One batch of antigen (Lederle, febrile diagnostic Brucella abortus antigen No. 110-128) gave repro-
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hr of incubation at 370C. E. coli and Shigella antibodies. 18 of the group of 23 SLE patients were matched for race, age, and sex with a group of hospitalized patients with pulmonary tuberculosis in the Tyler State Hospital, Tyler, Tex. All patients had confirmed disease of at least 6 months duration and were receiving antibiotic therapy for this condition. Sera were supplied by Dr. George Hurst, director of the Tyler State Hospital. The 18 pairs of SLE sera and matched tuberculosis sera were tested at the same time. Different lots of E. coli antigen were used, although the same lot was always used when SLE sera were compared with individual control groups. Antibody titers were determined by a passive lhemagglutination method using a microtitrator system (10), as modified by Wegmann and Smithies (11) . Endotoxins for testing of antibody to E. coli types 011 and 014 were prepared by phenol extraction of bacterial cultures followed by ethanol fractionation (12) . The endotoxin prepared in a single batch process gave consistent results at coating concentrations of 0.5%o in the case of E. coli 011 and 0.1% in the case of E. coli 014. A final concentration of 1.25%o human type 0 erythrocytes was used for agglutination tests. Other E. coli endotoxins were obtained from Difco, Inc. They were used in a 1: 1 dilution of the stock solution. Several different batches were used, accounting for some -variation in titer when the SLE were compared with different control groups. Shigella polyvalent antigen and specific Shigella serotypes, supplied through the courtesy of Doctors John Nelson and Kenneth C. Haltalin, were utilized as described by them (13) . The Shigella polyvalent antigen was a composite of equal amounts of all of the known individual types.
Statistical methods. The entire group of 23 SLE patients and 18 normal females were compared for significant differences in antibody titer. The results of the comparison of 18 SLE and 18 tuberculosis patients were carried out, using a method for matched pairs. All elements of the data in Table I were studied for significant correlations, using Pearson product moment correlation coefficients.
Other methods. 19S and 7S antibody titers were determined on fractions separated by sucrose density gradient centrifugation (15) . All sera showing the presence of antibody were fractionated. Continuous gradients between 10 and 40%o sucrose -were prepared in 0.01 M phosphate buffer, pH 7.2. 0.5 ml of serum was diluted to 1 ml with phosphatebuffered saline and layered on top of the gradient. Centrifugation was carried out in an SW-39 swinging bucket rotor for 15 hr at 35,000 rpm at 4VC. Gradients were separated by puncture of the bottom of the tube and collected in 10 fractions of 0.5 ml each. The fractions were dialyzed in the cold against a large volume of phosphate-buffered saline, pH 7.2, for 24 hr. Fractions one through nine were then tested for the presence of antibody. The Gamma globulin and a2-globulin levels were determined by serum paper electrophoresis. RESULTS Brucella antibody response. Table II shows the reciprocal antibody titers to Brucella antigen in the patients with SLE and Table III the results in the normal group. In Table IV are seen the geometric mean titers of antibody in both groups. It can be seen (Table  IV) that the antibody levels at 1, 4, and 12 wk were significantly reduced in the SLE patients. Whereas the normal subjects showed their maximal response early ( Fig. 1) , with a fall-off in titer after 4 wk, the patients showed a slow rise with attainment of maximum levels only at 4 wk. When the response of the 19S and 7S immunoglobulins at each time period was studied, at 1 wk (Fig. 2) , maximal antibody titers of the normal controls were noted in the lower part of the gradient where macroglobulin antibody is found. Little or no antibody titer was measured in tube six of the gradient where the 7S antibody is found. The SLE group showed low titers in the 19S end of the gradient and a slight, although not statistically significant elevation, in the 7S immunoglobulin area. The difference between the two groups was highly significant in tubes two, three, and four. At 4 wk (Fig.  2) , the antibody levels of the normals were virtually identical with those found at 1 wk, but the values of the SLE group had shown a twofold increase in tubes one to six, indicating an increase in both the 19S and 7S antibody. Significantly less antibody was still present in the macroglobulin region. At 12 wk (Fig. 2) , the normal group showed a fall in the level of macroglobulin antibody with somewhat increased levels in the light antibody region. The SLE patients showed a pronounced fall in all tubes with significantly lower levels again in the macroglobulin region (tubes two, three, and four).
Comparison of the macroglobulin antibody (tube three) and light antibody ( No significant relationship was found between Brucella whole serum antibody titers and the presence of renal involvement or with the level of the BUN (P = 0.10) (Table II) . Only four of the SLE patients had BUN levels above 30 mg/100 ml, and all of these produced significant amounts of antibody. In fact, the patient (F. S.) with the highest level, 80 mg/100 ml, demonstrated large amounts of antibody.
14 of the SLE patients were reimmunized with the same dosage of Brucella antigen. The increases in titer between 4 and 12 wk (Table VI) not reached for 4 wk. Study of the individual immunoglobulin titers by testing of sucrose density gradientseparated fractions showed low responses in both IgM and IgG with no gross differences noted. Studies on natural antibodies. These studies were carried out on the 23 patients with SLE and the 18 normal subjects previously immunized with Brucella antigen. In addition, to provide a matched control group with a chronic disease, 18 patients with active pulmonary tuberculosis, who were matched for age, sex, and race with the SLE group, were also studied. The patients with SLE showed significantly lower antibody levels 13 individual Shigella antigens and against a polyvalent antigen. Against 5 of the 13 individual antigens, the SLE sera showed significantly lower antibody levels than did the normal controls (Table XI) . In the case of the polyvalent antigen, the difference was not statistically significant. Only with respect to one antigen, S. sonnei, did the patients with SLE appear to have a significantly higher antibody level than the normal controls.
When the whole serum antibody levels to the same antigens were compared in patients with SLE and matched controls with pulmonary tuberculosis, significantly lower levels were observed against 7 of 13 antigens (Table  XII) . On testing the polyvalent antigen, the difference between the SLE patients and the pulmonary tuberculosis group again did not show a significant difference.
When density gradient ultracentrifugal analysis of the sera was carried out and the separated fractions tested with the Shigella polyvalent antigen, as found previously with the E. coli antigens, there was a statistically significant decrease in titer of macroglobulin antibody in the patients with SLE when compared with the normals (Table IX) . A significant increase of 7S antibody was also observed in the SLE patients. The matched (Table X) also showed a significantly lower level of macroglobulin antibody than the SLE patients but no significant difference in the light antibody. A summary of the antibody titers of whole serum and separated gradient fractions is compiled in Fig. 3 for the E. coli antigens tested and the Shigella polyvalent antigen.
DISCUSSION There have been a number of studies of the antibody response in SLE. Sarkany (&) found no significant difference from normal controls in the response 'to tetanus toxoid in 18 patients with discoid lupus erythematosus and 5 with SLE. Muschel (4), studying patients with SLE, hospitalized individuals and healthy young men, found no difference in titer of blood group isoagglutinins and antibody to Proteus 0 X-2 in the three groups, although there was a somewhat reduced titer of antistreptolysin 0 in the SLE patients. Lee and coworkers (14) found no difference in the response to a Rickettsial antigen between SLE patients and a control group. Meiselas, Lee, Zingale, and Richman (1), on the other hand, observed a greater response to stimulation with Brucella in patients with SLE than in a control group with other diseases, although not as high as in patients with rheumatoid arthritis. In this study, the inoculum used was five times as large as the dose employed in the present investigation. Two studies (16, 17) have subsequently failed to confirm the increased Brucella antibody response of patients with rheumatoid arthritis.
Whereas chronic Brucella infection is associated mainly with 7S antibody, the serum contains IgM antibody early in the course of infection (18) (19) (20) . In the present experiments, and as previously noted by Waller, Ellman, and Toone (17) , most of the antibody produced in the normal subjects in response to immunization with Brucella was macroglobulin antibody. In the SLE patients, the levels of macroglobulin antibody were significantly lower, and the levels of 7S antibody at 1 and 4 wk were slightly but not significantly higher in the patients with SLE than in the controls.
The effect of steroid administration on antibody formation is a factor for consideration in this study since 16 of the 23 SLE patients were receiving steroids at the time of immunization. The dosage administered to these patients was relatively low (average, 13 mg; range, 2.5-25 mg). However, no significant correlation between the steroid dosage and whole serum, 19S or 7S antibody titers to Brucella antigen was found in the SLE group. Inhibition of antibody production by steroids has been investigated in a number of species, using a variety of antigens (21, 22) . Mild suppression of the primary response in the mouse and rat has usually required doses of from 100 to 200 mg/kg of prednisolone. It is of interest that a study of the effect of Prednisone on Brucella antibody formation in the rat has actually shown an enhancement of antibody formation (23) . In man, dosages equivalent to or greater than those used in the present study did not affect antibody production (24, 25) .
Patients with renal disease in a state of advanced uremia have been shown to have a diminished humoral antibody response (26) . In the present study, however, the response to Brucella antigen appeared to be uninfluenced by the presence of renal involvement. This was presumably due to the fact that only one patient in the SLE group (F. S.) had a BUN level over 40 mg/ 100 ml. In fact, this patient, whose BUN was 80 mg/100 ml, produced large amounts of antibody. Further evidence for lack of influence of the renal disease on antibody titer was the failure to observe any statistical correlation between the BUN and Brucella antibody titer.
Since it has been observed that immunoglobulin levels in blacks tend to be higher than in whites (27) , it is of interest that the predominantly white control subjects had a higher antibody response to Brucella antigen than the predominantly black SLE group, providing evidence that race was not a factor in the reduced response observed in the SLE patients. Nevertheless, since the control subjects in the Brucella immunization studies were mainly white, for the natural antibody studies, an additional control group was carefully matched for race as well as -age and sex. In order to take into account the factor of chronic disease, moreover, this group was selected from patients with active pulmonary tuberculosis under treatment.
The titers of the E. coli natural antibodies of the control subjects were similar to those reported by Kunin (28) and Neter and associates (7) in normal populations.
The latter investigations tested large groups of normal subjects with several enteropathogenic E. coli and found that almost all individuals above the age of 12 had antibody to the organisms tested. Similarly, the titers to the Shigella organisms measured in the control subjects of the present study are consistent with those reported by Young, Lee, and Branche (8) in their population studies. It is of interest that when antibody titers to rat feces antigen, which cross-reacts with E. coli 014 (29) , were measured in patients with thyroiditis, rheumatoid arthritis, scleroderma, and SLE, the antibody levels of the patients with SLE were lower than in the other groups (30) .
In the present experiments, the natural antibody titers to E. coli in the normal controls were significantly higher than those of the SLE patients against 8 of 12 antigens studied. There was little difference in whole serum titer, however, in the case of the matched tuberculosis controls. With regard to the individual Shigella antigens, the SLE patients showed significantly lower titers than Decreased 19S Antibody Response to Bacterial Antigens in SLE 765 the normal group against 5 of 13 of the antigens studied, and when compared with the tuberculosis controls against 7 of the 13 antigens.
To compare the titers of the 19S and 7S natural antibodies to E. coli and Shigella in SLE with those of the control groups, five E. coli antigens and a Shigella polyvalent antigen, all selected on the basis of availability, were used. The SLE patients showed significantly lower 19S antibody titers compared with both control groups against four of the five E. coli antigens and the Shigella polyvalent antigen. It is of interest that against four of the antigens, the titer of 7S antibody was significantly greater in the SLE patients than in the controls (Fig.  3) .
Since patients with SLE are prone to elaborate a number of autoantibodies (31), the possibility must be considered that the decreased antibody formation noted in SLE may be a result of antigen competition (32) (44) , have also emphasized the deficient capacity of patients with SLE to resist infection. Thus, infection has been shown to play a prominent role in the morbidity and mortality of SLE and this has been found to be true not only in those series collected after the introduction of steroid therapy (31, 41) , but also in series accumulated mainly in the presteroid era (42, 44, 45) . The role of macroglobulin antibody in protection against bacterial infection has been supported by several recent studies (46, 47) . IgM antibodies are more active than IgG antibodies in agglutination and in lytic reactions (48) . Therefore, macroglobulin antibody would appear to be of greater importance in the initial defense of the host against bacterial invasion (49) . For these reasons, the observed lowered macroglobulin antibody levels in the patients with SLE may bear significantlyupon the increased frequency of infection described.
